The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia

BACKGROUND: Establishing preclinical models is essential for novel drug discovery in schizophrenia. Most existing models are characterized by abnormalities in behavioral readouts, which are informative, but do not necessarily translate to the symptoms of the human disease. Therefore, there is a nece...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Martins-de-Souza, Daniel, Alsaif, Murtada, Ernst, Agnes, Harris, Laura W, Aerts, Nancy, Lenaerts, Ilse, Peeters, Pieter J, Amess, Bob, Rahmoune, Hassan, Bahn, Sabine, Guest, Paul C
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359223/
https://ncbi.nlm.nih.gov/pubmed/22420779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-5-146
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak